2023 annual financial data
Anixa Biosciences 2023 Operating margin
Anixa Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was -5,243.33%.
Operating income was -11,011,000 USD and net income was -9,811,000 USD.
Operating cash flow was -6,209,000 USD.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 210,000 USD
- Operating income
- -11,011,000 USD
- Net income
- -9,811,000 USD
- Operating cash flow
- -6,209,000 USD